The influence of transforming growth factor-β1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin a and a calcium channel blocker

Journal of Periodontology

Volumn 72, Issue 6, 2001, Pages 808-814

  Linden, Gerard J ^a   Haworth, Simone E ^b   Maxwell, A Peter ^c   Poulton, Kay V ^b   Dyer, Philip A ^b   Middleton, Derek ^c   Irwin, Christopher R ^a   Marley, John J ^a   McNamee, Peter ^c   Short, Colin D ^b   Hull, Peter S ^d   James, Jacqueline A ^d  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Calcium channel blockers adverse effects; Cyclosporin A adverse reactions; Gingival hyperplasia etiology; Growth factors, transforming; Polymorphism, genetic

Indexed keywords

AMINO ACID; ARGININE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; LEUCINE; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ALLELISM; AMINO ACID SUBSTITUTION; ARTICLE; CODON; DISEASE SEVERITY; DNA POLYMORPHISM; GINGIVA OVERGROWTH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY;

ADULT; AGE FACTORS; ALLELES; ANALYSIS OF VARIANCE; ARGININE; CALCIUM CHANNEL BLOCKERS; CHI-SQUARE DISTRIBUTION; CODON; CONFIDENCE INTERVALS; CYCLOSPORINE; DNA; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; GINGIVAL OVERGROWTH; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUCINE; LOGISTIC MODELS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PROLINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0034972681     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.6.808     Document Type: Article

References (40)

1. Nabel G. A transformed view of cyclosporine. Nature 1999;397:471-472.
2. Thomason J, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
3. Hefti A, Eshenaur A, Hassell T, Stone C. Gingival overgrowth in cyclosporine A-treated multiple sclerosis patients. J Periodontol 1994;65:744-749.
4. King G, Fullinfaw R, Higgins T, Walker R, Francis D, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium anatagonists. J Clin Periodontol 1993;20:286-293.
5. Thomason J, Seymour R, Ellis J, et al. Determinants of gingival overgrowth severity in organ transplant patients. An examination of the role of HLA phenotype. J Clin Periodontol 1996;23:628-634.
6. Spratt H, Boomer S, Irwin CR, et al. Cyclosporin-associated gingival overgrowth in renal transplant recipients. Oral Dis 1999;5:27-31.
7. Rostock MH, Hiram RF, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
8. Mariani G, Calastrini C, Caricini F, Bergamini L, Calastrini F, Stabellini G. Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth. J Periodontol 1996;67:21-27.
9. Bartold PM. Regulation of gingival fibroblast growth and synthetic activity by cyclosporine A in vitro. J Periodont Res 1989;24:314-321.
10. Barber MT, Savage NW, Seymour GJ. The effects of cyclosporin and lipopolysaccharide on fibroblasts: Implications for cyclosporin-induced gingival overgrowth. J Periodontol 1992;63:397-404.
11. James JA, Irwin CR, Linden GJ. The effects of culture environment on the response of human gingival fibroblasts to cyclosporin A. J Periodontol 1995;66:339-344.
12. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997;68:443-447.
13. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1 beta and interleukin-6 expression in gingiva: Implications for gingival overgrowth. J Periodontol 1999;70:294-300.
14. Roberts AB, Sporn MB. The transforming growth factors-β. In: Sporn MB, Roberts AB, eds. The Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors. New York: Springer-Verlag; 1990: 419-472.
15. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor β. Biochim Biophys Acta 1990;1032:79-87.
16. Ignotz RS, Massague J. Tranforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345.
17. Overall CM, Wrana JL, Sodek J. Transforming growth factor-β regulation of collagenase, 72 KDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Conn Tissue Res 1989; 20:289-294.
18. Gauldie J, Jordana M, Cox G. Cytokines and pulmonary fibrosis. Thorax 1993;48:931-935.
19. Peters H, Noble NA, Border WA. Transforming growth factor-beta in human glomerular injury. Curr Opin Nephrol Hypertens 1997;6:389-393.
20. 1 autocrine stimulation. J Periodont Res 1999;34:457-463.
21. Wolf G, Thaiss F, Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanisms of cyclosporines antiproliferative effects. Transplantation 1995;60:237-241.
22. Shin GT, Khanna A, Ding R, et al. In vivo expression of transforming growth factor beta 1 in humans: stimulation by cyclosporine. Transplantation 1998;65:313-318.
23. Hutchison IV. An endothelin-transforming growth factor beta pathway in the nephrotoxicity of immunosuppressive drugs. Curr Opin Nephrol Hypertens 1998;7:665-671.
24. Khanna AK, Hosenpud JD. Cyclosporine induces the expression of the cyclin inhibitor p21. Transplantation 1999;67:1262-1268.
25. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999;397:530-534.
26. James JA, Irwin CR, Linden GJ. Gingival fibroblast response to cyclosporin A and transforming growth factor beta 1. J Periodont Res 1998;33:40-48.
27. 1 gene in relation to myocardial infarction and blood pressure. Hypertension 1996;28:881-887.
28. 1 gene. Transplantation 1998;66:1014-1020.
29. Seymour R, Smith D, Turnbull D. The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985;12:413-419.
30. James JA, Marley JJ, Jamal S, et al. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol 2000;27:109-115.
31. Miller S, Dykes D, Polesky H. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988;16:1215.
32. Ryan P, Edwards CO. Systematic introduction of proline in a eukaryotic signal sequence suggests asymmetry within the hydrophobic core. J Biol Chem 1995;270: 27876-27879.
33. Yamamoto Y, Taniyama Y, Kikuchi M. Important role of the proline residue in the signal sequence that directs the secretion of human lysozyme in Saccharomyces cerevisiae. Biochemistry 1989;28:2728-2732.
34. Lu HM, Yamada H, Mizushima S. A proline residue near the amino terminus of the mature domain of secretory proteins lowers the level of proton motive force required for translocation. J Biol Chem 1991;266:9977-9982.
35. Yamada Y, Miyauchi A, Goto J, et al. Association of polymorphism of the transforming growth factor beta 1 gene with susceptibility to osteoporosis in post-menopausal Japanese women. J Bone Miner Res 1998; 13:1569-1576.
36. Marley JJ, Phenix KV, Irwin CR, Thompson J, Robinson PA, Linden GJ. Signal recognition particle receptor is down regulated in a rat model of cyclosporin A induced gingival overgrowth. J Periodont Res 1999;34:188-196.
37. Shehata M, Cope GM, Johnson TM, Raftry AT, Naha AM. Cyclosporine enhances the expression of TGF-β in the juxtaglomerular cells of the rat kidney. Kidney Int 1995;48:1487-1496.
38. Khanna AK, Cairns VR, Becker CG, Hosenpud JD. TGF-β: a link between immunosuppression, nephrotoxicity and cyclosporin A. Transplant Proc 1998;30:944-945.
39. Steinsvoll S, Halstensen TS, Schenck K. Extensive expression of TGF-β1 in chronically-inflamed periodontal tissue. J Clin Periodontol 1999;26:366-373.
40. Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor β, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. JPeriodont Res 1996;31:545-555.